Worth noting also that ISCO is tiny and only has a US$6.5m Mcap....so one would imagine that CYP should have no problems getting the ok for second cohort to progress with a couple of Nobel potentials floating around.
If they can provide an update and say these patients are going better than expected would be game on.
First Cohort Enrollment Completed in CYP-001 Clinical Trial; Reiterate Buy, page-36
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $36.11M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.5¢ | 20.0¢ | $13.43K | 65.55K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 109917 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 9225 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |